Our programs have supported over 100 different patient populations in 38 countries, and improved adherence by an average of 23%.
Our program resulted in an overall increase in treatment of 22%, improving brand choice and reducing missed infusions. See how.
Our program increased script to fill from 68% to 86% with a 25:1 ROI. See how.
Our program increased product use by 2.31 additional applications per patient during the course of treatment and increased revenue by 55% per patient. See how.
Our program increased the percentage of patients completing therapy from 63% to 74%. See how.